Zobrazeno 1 - 10
of 280
pro vyhledávání: '"Stravodimou, A"'
Autor:
Petit, P.-F., Daoudlarian, D., Latifyan, S., Bouchaab, H., Mederos, N., Doms, J., Abdelhamid, K., Ferahta, N., Mencarelli, L., Joo, V., Bartolini, R., Stravodimou, A., Shabafrouz, K., Pantaleo, G., Peters, S., Obeid, M.
Publikováno v:
In Annals of Oncology
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Solange Peters, Michel Obeid, Craig Fenwick, Roger Hullin, Rita Godinho, Alessandra Noto, Athina Stravodimou, Sarah Hugelshofer
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 6 (2023)
Cytokine storm induced by anti-human epidermal growth factor receptor-2 (HER2) therapies has not been reported. We report a patient with breast cancer treated with trastuzumab/pertuzumab who developed severe biventricular dysfunction and cardiogenic
Externí odkaz:
https://doaj.org/article/263878f22e9f455aae1d99c65c9df67a
Autor:
Valentina Scabia, Ayyakkannu Ayyanan, Fabio De Martino, Andrea Agnoletto, Laura Battista, Csaba Laszlo, Assia Treboux, Khalil Zaman, Athina Stravodimou, Didier Jallut, Maryse Fiche, Philip Bucher, Giovanna Ambrosini, George Sflomos, Cathrin Brisken
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-15 (2022)
The role of progesterone receptor (PR) and its interplay with estrogen receptor (ER) in breast cancer is controversial. Here, the authors demonstrate that PR can have an ER-independent role in breast cancer growth and metastasis and that its effects
Externí odkaz:
https://doaj.org/article/e90383a7e88449f6abdfb06422e18297
Publikováno v:
Actas Dermo-Sifiliográficas, Vol 113, Iss 10, Pp 988-990 (2022)
Externí odkaz:
https://doaj.org/article/ba1f1a5c670845c2a7f4abe4de5511b3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Actas Dermo-Sifiliográficas, Vol 113, Iss 10, Pp T988-T990 (2022)
Externí odkaz:
https://doaj.org/article/6c00410af9234509b2a3eb32e050b0c2
Intraductal xenografts show lobular carcinoma cells rely on their own extracellular matrix and LOXL1
Autor:
George Sflomos, Laura Battista, Patrick Aouad, Fabio De Martino, Valentina Scabia, Athina Stravodimou, Ayyakkannu Ayyanan, Assia Ifticene‐Treboux, RLS, Philipp Bucher, Maryse Fiche, Giovanna Ambrosini, Cathrin Brisken
Publikováno v:
EMBO Molecular Medicine, Vol 13, Iss 3, Pp 1-19 (2021)
Abstract Invasive lobular carcinoma (ILC) is the most frequent special histological subtype of breast cancer, typically characterized by loss of E‐cadherin. It has clinical features distinct from other estrogen receptor‐positive (ER+) breast canc
Externí odkaz:
https://doaj.org/article/8496cd22d6914407af3da1471f234dcb
Autor:
Carole Bandiera, Evelina Cardoso, Isabella Locatelli, Antonia Digklia, Khalil Zaman, Antonella Diciolla, Valérie Cristina, Athina Stravodimou, Aedo Lopez Veronica, Ana Dolcan, Apostolos Sarivalasis, Aikaterini Liapi, Hasna Bouchaab, Angela Orcurto, Jennifer Dotta-Celio, Solange Peters, Laurent Decosterd, Nicolas Widmer, Dorothea Wagner, Chantal Csajka, Marie Paule Schneider
Publikováno v:
JMIR Research Protocols, Vol 10, Iss 6, p e30090 (2021)
BackgroundThe strengthening or substitution of intravenous cytotoxic chemotherapy cycles by oral targeted anticancer therapies, such as protein kinase inhibitors (PKIs), has provided impressive clinical benefits and autonomy as well as a better quali
Externí odkaz:
https://doaj.org/article/04775837df1f491490dee20da4b49c14
Autor:
Perrine Courlet, Evelina Cardoso, Carole Bandiera, Athina Stravodimou, Jean-Philippe Zurcher, Haithem Chtioui, Isabella Locatelli, Laurent Arthur Decosterd, Léa Darnaud, Benoit Blanchet, Jérôme Alexandre, Anna Dorothea Wagner, Khalil Zaman, Marie Paule Schneider, Monia Guidi, Chantal Csajka
Publikováno v:
Pharmaceutics, Vol 14, Iss 7, p 1317 (2022)
Neutropenia is the most frequent dose-limiting toxicity reported in patients with metastatic breast cancer receiving palbociclib. The objective of this study was to investigate the pharmacokinetic–pharmacodynamic (PK/PD) relationships for toxicity
Externí odkaz:
https://doaj.org/article/74f52fb719014d18874ee81cbe9b0bad